HY-136527-50mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-148748-10mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-100mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-25mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-5mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-50mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-151462-10mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-100mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-25mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-5mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-151462-50mg
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-10mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-100mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-5mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582-50mg
|
MedChemexpress LLC
|
Sonidegib (diphosphate) [CAS 1218778-77-8]
|
|
Cancer-programmed cell death
|
|
HY-16582A-10mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-100mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-5mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-16582A-50mg
|
MedChemexpress LLC
|
Sonidegib [CAS 956697-53-3]
|
|
Cancer-programmed cell death
|
|
HY-W774905-10mg
|
MedChemexpress LLC
|
Diallate [CAS 2303-16-4]
|
|
|
|
HY-W774905-5mg
|
MedChemexpress LLC
|
Diallate [CAS 2303-16-4]
|
|
|
|
HY-10596-1mL
|
MedChemexpress LLC
|
BMS-688521 [CAS 893397-44-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-124628-1mL
|
MedChemexpress LLC
|
IPI-9119 [CAS 1346564-56-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-131034-1mL
|
MedChemexpress LLC
|
LP-922056 [CAS 1365060-22-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-151462-1mL
|
MedChemexpress LLC
|
RP-6685 [CAS 2832047-80-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|